Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-03-2015 | Basic Science

BAG3 protects against hyperthermic stress by modulating NF-κB and ERK activities in human retinoblastoma cells

Authors: Tatsuya Yunoki, Yoshiaki Tabuchi, Atsushi Hayashi, Takashi Kondo

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 3/2015

Abstract

Purpose

BCL2-associated athanogene 3 (BAG3), a co-chaperone of HSP70, is a cytoprotective and anti-apoptotic protein that acts against various stresses, including heat stress. Here, we examined the effect of BAG3 on the sensitivity of human retinoblastoma cells to hyperthermia (HT).

Methods

We examined the effects of BAG3 knockdown on the sensitivity of Y79 and WERI-Rb-1cells to HT (44 °C, 1 h) by evaluating apoptosis and cell proliferation using western blotting, real-time quantitative PCR (qPCR), flow cytometry, and a WST-8 assay kit. Furthermore, we examined the effects of activating nuclear factor-kappa B (NF-κB) and extracellular signal-regulated kinase (ERK) using western blotting and real time qPCR.

Results

HT induced considerable apoptosis along with the activation of caspase-3 and chromatin condensation. The sensitivity of Y79 and WERI-Rb-1 cells to HT was significantly enhanced by BAG3 knockdown. Compared to HT alone, the combination of BAG3 knockdown and HT reduced phosphorylation of the inhibitors of kappa B α (IκBα) and p65, a subunit of NF-κB, and degraded IκB kinase γ (IKKγ) during the recovery period after HT. Furthermore, BAG3 knockdown increased the HT-induced phosphorylation of ERK after HT treatment, and the ERK inhibitor U0126 significantly improved the viability of the cells treated with a combination of BAG3 knockdown and HT.

Conclusions

The silencing of BAG3 seems to enhance the effects of HT, at least in part, by maintaining HT-induced inactivity of NF-κB and the phosphorylation of ERK. These findings indicate that BAG3 may be a potential molecular target for modifying the outcomes of HT in retinoblastoma.

MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE (2006) Retinoblastoma incidence and survival in European children (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2092–2102CrossRefPubMed

Classon M, Harlow E (2002) The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2:910–917CrossRefPubMed

Lin P, O'Brien JM (2009) Frontiers in the management of retinoblastoma. Am J Ophthalmol 148:192–198CrossRefPubMed

Shields CL, Lally SE, Leahey AM, Jabbour PM, Caywood EH, Schwendeman R, Shields JA (2014) Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Curr Opin Ophthalmol 5:374–385CrossRef

Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM (1996) Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114:1330–1338CrossRefPubMed

Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT (1997) Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104:2101–2111CrossRefPubMed

Inomata M, Kaneko A, Kunimoto T, Saijo N (2002) In vitro thermo- and thermochemo-sensitivity of retinoblastoma cells from surgical specimens. Int J Hyperthermia 18:50–61CrossRefPubMed

Choi EK, Park SR, Lee JH, Chung HS, Ahn HE, Rhee YH, Lim BU, Park HJ (2003) Induction of apoptosis by carboplatin and hyperthermia alone or combined in WERI human retinoblastoma cells. Int J Hyperth 19:431–443CrossRef

Abramson DH, Schefler AC (2004) Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Ophthalmology 111:984–991CrossRefPubMed

10.

Shields CL, Santos MC, Diniz W, Gündüz K, Mercado G, Cater JR, Shields JA (1999) Thermotherapy for retinoblastoma. Arch Ophthalmol 117:885–893CrossRefPubMed

11.

Parsell DA, Lindquist S (1993) The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Ann Rev Genet 27:437–496CrossRefPubMed

12.

Ohtsuka K, Hata M (2000) Molecular chaperone function of mammalian Hsp70 and Hsp40- A review. Int J Hyperth 16:231–245CrossRef

13.

Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G (2006) Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5:2592–2601CrossRefPubMed

14.

Takayama S, Xie Z, Reed JC (1999) An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 274:781–786CrossRefPubMed

15.

Rosati A, Ammirante M, Gentilella A, Basile A, Festa M, Pascale M, Marzullo L, Melisario MA, Tosco A, Franceschelli S, Moltedo O, Paqliuca G, Lerose R, Turco MC (2007) Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol 39:1337–1342CrossRefPubMed

16.

Franceschelli S, Rosati A, Lerose R, De Nicola S, Turco MC, Pascale M (2008) Bag3 gene expression is regulated by heat shock factor 1. J Cell Physiol 215:575–577CrossRefPubMed

17.

Liao Q, Ozawa F, Friess H, Zimmermann A, Takayama S, Reed JC, Kleeff J, Büchler MW (2001) The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett 503:151–157CrossRefPubMed

18.

Kariya A, Tabuchi Y, Yunoki T, Kondo T (2013) Identification of common gene networks responsive to mild hyperthermia in human cancer cells. Int J Mol Med 32:195–202PubMed

19.

Chiappetta G, Ammirante M, Basile A, Rosati A, Festa M, Monaco M, Vuttariello E, Pasquinelli R, Arra C, Zerilli M, Todaro M, Stassi G, Pezzullo L, Gentilella A, Tosco A, Pascale M, Marzullo L, Belisario MA, Turco MC, Leone A (2007) The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocrinol Metab 92:1159–1163CrossRefPubMed

20.

Staibano S, Mascolo M, Di Benedetto M, Vecchione ML, Ilardi G, Di Lorenzo G, Autorino R, Salerno V, Morena A, Rocco A, Turco MC, Morelli E (2010) BAG3 protein delocalisation in prostate carcinoma. Tumor Biol 31:461–469CrossRef

21.

Wang HQ, Liu BQ, Gao YY, Meng X, Guan Y, Zhang HY, Du ZX (2009) Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. Br J Pharmacol 158:1405–1412CrossRefPubMedCentralPubMed

22.

Festa M, Del Valle L, Khalili K, Franco R, Scognamiglio G, Graziano V, De Laurenzi V, Turco MC, Rosati A (2011) BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol 178:2504–2512CrossRefPubMedCentralPubMed

23.

Suzuki M, Iwasaki M, Sugio A, Hishiya A, Tanaka R, Endo T, Takayama S, Saito T (2011) BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett 303:65–71CrossRefPubMed

24.

Liu P, Xu B, Li J, Lu H (2009) BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett 583:401–406CrossRefPubMed

25.

Du ZX, Meng X, Zhang HY, Guan Y, Wang HQ (2008) Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in thyroid cancer cells. Biochem Biophys Res Commun 369:894–898CrossRefPubMed

26.

Wang HQ, Liu HM, Zhang HY, Guan Y, Du ZX (2007) Transcriptional upregulation of BAG3 upon proteasome inhibition. Biochem Biophys Res Commun 365:381–385CrossRefPubMed

27.

Yunoki T, Kariya A, Kondo T, Hayashi A, Tabuchi Y (2013) The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells. Cancer Lett 335:52–57CrossRefPubMed

28.

Chuma M, Sakamoto N, Nakai A, Hige S, Nakanishi M, Natsuizaka M, Suda G, Sho T, Hatanaka K, Matsuno Y, Yokoo H, Kamiyama T, Taketomi A, Fujii G, Tashiro K, Hikiba Y, Fujimoto M, Asaka M, Maeda S (2014) Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase. Carcinogenesis 35:272–281CrossRefPubMed

29.

Bassères DS, Baldwin AS (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25:6817–6830CrossRefPubMed

30.

Wang CY, Mayo MW, Baldwin AS Jr (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274:784–787CrossRefPubMed

31.

Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M, Pascale M, d'Avenia M, Marzullo L, Belisario MA, De Marco M, Barbieri A, Giudice A, Chiappetta G, Vuttariello E, Monaco M, Bonelli P, Salvatore G, Di Benedetto M, Deshmane SL, Khalili K, Turco MC, Leone A (2010) IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci U S A 107:7497–7502CrossRefPubMedCentralPubMed

32.

Rosati A, Basile A, Falco A, Avenia M, Festa M, Graziano V, De Laurenzi V, Arra C, Pascale M, Turco MC (2012) Role of BAG3 protein in leukemia cell survival and response to therapy. Biochim Biophys Acta 1826:365–369PubMed

33.

Poulaki V, Mitsiades CS, Joussen AM, Lappas A, Kirchhof B, Mitsiades N (2002) Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability. Am J Pathol 161:2229–2240CrossRefPubMedCentralPubMed

34.

Qu Y, Zhou F, Dai X, Wang H, Shi J, Zhang X, Wang Y, Wei W (2011) Clinicopathologic significances of nuclear expression of nuclear factor-κB transcription factors in retinoblastoma. J Clin Pathol 64:695–700CrossRefPubMed

35.

Falco A, Festa M, Basile A, Rosati A, Pascale M, Florenzano F, Nori SL, Nicolin V, Di Benedetto M, Vecchione ML, Arra C, Barbieri A, De Laurenzi V, Turco MC (2012) BAG3 controls angiogenesis through regulation of ERK phosphorylation. Oncogene 31:5153–5161CrossRefPubMed

36.

Xiao H, Cheng S, Tong R, Lv Z, Ding C, Du C, Xie H, Zhou L, Wu J, Zheng S (2014) BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma. Lab Invest 94:252–261CrossRefPubMed

37.

Aravindan N, Shanmugasundaram K, Natarajan M (2009) Hyperthermia induced NFkappaB mediated apoptosis in normal human monocytes. Mol Cell Biochem 327:29–37CrossRefPubMed

38.

Kokura S, Yoshida N, Ueda M, Imamoto E, Ishikawa T, Takagi T, Naito Y, Okanoue T, Yoshikawa T (2003) Hyperthermia enhances tumor necrosis factor alpha-induced apoptosis of a human gastric cancer cell line. Cancer Lett 201:89–96CrossRefPubMed

39.

Mattson D, Bradbury CM, Bisht KS, Curry HA, Spitz DR, Gius D (2004) Heat shock and the activation of AP-1 and inhibition of NF-kappa B DNA-binding activity: possible role of intracellular redox status. Int J Hyperth 20:224–233CrossRef

40.

Pajonk F, van Ophoven A, McBride WH (2005) Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells. Cancer Res 65:4836–4843CrossRefPubMed

41.

Yunoki T, Tabuchi Y, Hayashi A, Kondo T (2013) Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells. Invest Ophthalmol Vis Sci 54:8353–8363CrossRefPubMed

42.

Park JB (2011) Protective effects of veskamide, enferamide, becatamide, and oretamide on H2O2-induced apoptosis of PC-12 cells. Phytomedicine 18:843–847CrossRefPubMed

43.

Furusawa Y, Iizumi T, Fujiwara Y, Zhao QL, Tabuchi Y, Nomura T, Kondo T (2012) Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress. Apoptosis 17:102–112CrossRefPubMed

44.

Tabuchi Y, Sugahara Y, Ikegame M, Suzuki N, Kitamura K, Kondo T (2013) Genes responsive to low-intensity pulsed ultrasound in MC3T3-E1 preosteoblast cells. Int J Mol Sci 14:22721–22740CrossRefPubMedCentralPubMed

45.

Xia H, Karasawa K, Hanyu N, Chang TC, Okamoto M, Kiguchi Y, Kawakami M, Itazawa T (2006) Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma. Int J Hyperth 22:613–621CrossRef

46.

Aktas M, de Jong D, Nuyttens JJ, van der Zee J, Wielheesen DH, Batman E, Burger CW, Ansink AC (2007) Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study. Eur J Obstet Gynecol Reprod Biol 133:100–104CrossRefPubMed

47.

Boiani M, Daniel C, Liu X, Hogarty MD, Marnett LJ (2013) The stress protein BAG3 stabilizes Mcl-1 protein and promotes survival of cancer cells and resistance to antagonist ABT-737. J Biol Chem 288:6980–6990CrossRefPubMedCentralPubMed

48.

Zhang Y, Wang JH, Lu Q, Wang YJ (2012) Bag3 promotes resistance to apoptosis through BCL-2 family members in non-small cell lung cancer. Oncol Rep 27:109–113PubMed

49.

Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18:2195–2224CrossRefPubMed

50.

Rubinfeld H, Seger R (2005) The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol 31:151–174CrossRefPubMed

51.

Park SW, Kim YI (2013) Triptolide induces apoptosis of PMA-treated THP-1 cells through activation of caspases, inhibition of NF-κB and activation of MAPKs. Int J Oncol 43:1169–1175PubMed

52.

Wang X, Martindale JL, Holbrook NJ (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275:39435–39443CrossRefPubMed

Title: BAG3 protects against hyperthermic stress by modulating NF-κB and ERK activities in human retinoblastoma cells
Authors: Tatsuya Yunoki
Yoshiaki Tabuchi
Atsushi Hayashi
Takashi Kondo
Publication date: 01-03-2015
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 3/2015
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-014-2874-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

BAG3 protects against hyperthermic stress by modulating NF-κB and ERK activities in human retinoblastoma cells

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2015

Massive and diffuse elastosis of the temporal artery

Ocular Blood Flow, Editors: Kiel JW, Schmetterer L, (2012), ISBN 978-3-540-69468-7, Springer

Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats

Safety evaluation of “retina implant alpha IMS”—a prospective clinical trial

A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada Disease

Evaluation of filtering blebs exhibiting transconjunctival oozing using anterior segment optical coherence tomography